| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Howton David T | Chief Operating Officer | Dec 03, 2024 | Sale | $5.60 | 5,072 | 28,396 | 15,663 | Dec 04, 2024, 05:04 PM | |
| SLDB | Solid Biosciences Inc. | Howton David T | Chief Operating Officer | Dec 04, 2023 | Sale | $2.78 | 5,367 | 14,920 | 7,684 | Dec 05, 2023, 02:32 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Jun 22, 2020 | Option Exercise | $25.76 | 105,122 | 2,708,440 | 136,993 | Jun 22, 2020, 09:17 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Jun 22, 2020 | Sale | $170.88 | 105,122 | 17,962,831 | 130,984 | Jun 22, 2020, 09:17 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Dec 13, 2019 | Sale | $125.50 | 78,000 | 9,789,000 | 25,171 | Dec 17, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Dec 13, 2019 | Option Exercise | $21.48 | 78,000 | 1,675,439 | 103,171 | Dec 17, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $107.02 | 2,804 | 300,084 | 25,171 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $16.13 | 34,272 | 552,667 | 36,993 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Nov 22, 2019 | Sale | $105.00 | 25,000 | 2,625,000 | 18,703 | Nov 26, 2019, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Mar 28, 2019 | Option Exercise | $118.68 | 2,362 | 280,322 | 18,703 | Mar 29, 2019, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Feb 01, 2019 | Option Exercise | $21.65 | 21,500 | 465,391 | 49,571 | Feb 01, 2019, 08:25 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Feb 01, 2019 | Sale | $140.00 | 30,000 | 4,200,000 | 19,571 | Feb 01, 2019, 08:25 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Aug 08, 2018 | Option Exercise | $121.02 | 6,800 | 822,936 | 28,071 | Aug 08, 2018, 06:14 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 16, 2018 | Option Exercise | $13.85 | 50,000 | 692,691 | 72,719 | Jul 17, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 16, 2018 | Sale | $136.46 | 50,000 | 6,823,000 | 34,871 | Jul 17, 2018, 06:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | May 22, 2018 | Option Exercise | $89.22 | 1,566 | 139,719 | 34,871 | May 24, 2018, 06:05 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $81.22 | 680 | 55,230 | 31,118 | Mar 16, 2018, 06:12 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $22.15 | 2,500 | 55,382 | 31,727 | Mar 16, 2018, 06:12 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Aug 03, 2017 | Option Exercise | $37.88 | 4,642 | 175,839 | 29,298 | Aug 07, 2017, 04:40 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 20, 2017 | Sale | $41.00 | 25,000 | 1,025,000 | 22,301 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 21, 2017 | Option Exercise | $20.56 | 1,000 | 20,565 | 23,301 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Jul 20, 2017 | Option Exercise | $13.71 | 25,000 | 342,750 | 41,357 | Jul 21, 2017, 09:46 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Mar 19, 2017 | Option Exercise | $30.30 | 152 | 4,606 | 22,301 | Mar 21, 2017, 06:07 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 22,453 | Nov 10, 2016, 08:27 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Sep 22, 2016 | Option Exercise | $13.90 | 7,000 | 97,300 | 28,453 | Sep 26, 2016, 04:19 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Sep 22, 2016 | Sale | $60.00 | 7,000 | 420,000 | 21,453 | Sep 26, 2016, 04:19 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Sep 19, 2016 | Option Exercise | $13.90 | 8,000 | 111,200 | 11,168 | Sep 21, 2016, 09:28 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Sep 19, 2016 | Sale | $50.00 | 9,304 | 465,200 | 21,453 | Sep 21, 2016, 09:28 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | SVP, General Counsel | Aug 31, 2016 | Option Exercise | $26.07 | 898 | 23,411 | 3,168 | Sep 02, 2016, 04:32 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Howton David T | SVP & Chief Legal Officer | Feb 02, 2012 | Option Exercise | $0.01000 | 10,166 | 102 | 19,437 | Feb 06, 2012, 04:05 PM | |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Howton David T | SVP | Sep 01, 2011 | Sale | $44.29 | 328 | 14,527 | 9,271 | Sep 07, 2011, 01:51 PM |
Menu